UF Researchers Awarded $3.5 Million Grant to Study Outcomes With Genetic Information to Guide Blood Thinning Therapy

Researchers at the University of Florida have received a $3.5 million grant from the National Heart, Lung and Blood Institute, or NHLBI, to study the effect of using genetic information to guide therapy after an angioplasty heart procedure to prevent heart attacks and strokes.

“In previous studies, we have demonstrated the feasibility and clinical benefits of using a patient’s genetic information to guide prescribing decisions after percutaneous coronary intervention,” said Larisa Cavallari, Pharm.D., BCPS, FCCP, an associate professor of pharmacotherapy and translational research in the UF College of Pharmacy and one of the principal investigators on the grant. “Now we want to build upon that research to determine what other factors, such as ancestry, medical history, and other genotypes, influence outcomes with genotype-guided therapy for heart patients.”

Learn more about UF Researchers Awarded $3.5 Million Grant to Study Outcomes With Genetic Information to Guide Blood Thinning Therapy.